Stay updated on Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Sign up to get notified when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.

Latest updates to the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page
- CheckyesterdayChange DetectedAn NIH-wide notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434. It appears above the clinical trial record content.SummaryDifference0.8%

- Check8 days agoChange DetectedThe site revision label in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check15 days agoChange DetectedThe footer revision changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check36 days agoChange DetectedThe record history adds a new revision entry 'Revision: v3.7.0' and removes the previous 'Revision: v3.6.6', signaling an update to the study record history.SummaryDifference0.1%

- Check57 days agoChange DetectedThe record history now includes a new latest revision labeled v3.6.6, indicating a more recent update to the page. The older revision labeled v3.6.5 has been removed from the visible history.SummaryDifference0.1%

- Check79 days agoChange DetectedThe record history now includes a new revision labeled v3.6.5, indicating an update to the study record after the previous v3.6.4 revision. This appears to be a routine metadata update rather than a substantive change to study details.SummaryDifference0.1%

Stay in the know with updates to Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Evinacumab Safety in Homozygous Familial Hypercholesterolemia Clinical Trial page.